LIGAND PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-GRANT THORNTON LLP - March 3, 2010

Attached files

file filename
10-K - FORM 10-K - LIGAND PHARMACEUTICALS INCd10k.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - LIGAND PHARMACEUTICALS INCdex211.htm
EX-32.1 - CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 906 - LIGAND PHARMACEUTICALS INCdex321.htm
EX-31.2 - CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 302 - LIGAND PHARMACEUTICALS INCdex312.htm
EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-BDO SEIDMAN, LLP - LIGAND PHARMACEUTICALS INCdex232.htm
EX-32.2 - CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 906 - LIGAND PHARMACEUTICALS INCdex322.htm
EX-10.361 - AMENDMENT TO DISCOVERY COLLABORATION AGREEMENT - LIGAND PHARMACEUTICALS INCdex10361.htm
EX-31.1 - CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 302 - LIGAND PHARMACEUTICALS INCdex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated March 3, 2010, with respect to the consolidated financial statements, schedule, and internal control over financial reporting included in the Annual Report of Ligand Pharmaceuticals Incorporated on Form 10-K for the year ended December 31, 2009. We hereby consent to the incorporation by reference of said reports in the Registration Statement of Ligand Pharmaceuticals Incorporated on Forms S-8 (File No. 333-160132, effective June 22, 2009 and File No. 333-131029, effective June 18, 2007).

/s/ Grant Thornton LLP

San Diego, California

March 3, 2010

Stock widget

Investing forum

LIGAND PHARMACEUTICALS INC Reports